TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Shanghai's 8763 medicines are suspended! Involving hundreds of drug firms
 
Author:中国铭铉 企划部  Release Time:2017-6-13 10:06:00  Number Browse:584
 
Medical network, June 13, 12, Shanghai sun medicine procurement network published the notice about the state of the closed no purchasing record drug purchase ", a total of 8763 drug drug market in Shanghai was suspended. 
 
 
 
In 2017, according to the implementation of health care medical establishment that decide a dot, dynamic adjustment of drug bidding results announcement concerning the matters, the scope of this dynamic adjustment of the drugs in this city a sun platform no purchasing record throughout the year in 2016, the procurement status as of the date of the notice issued, stop buying qualification. 
 
And if the purchasing qualification needs to be resumed, the new rules for applying drug rules will be changed in 2017. 
 
New application drugs are different kinds of medicines, such as variety, dosage form, specification (quantity, quantity, loading), packing method, enterprise name and so on. 
 
If a drug that closes the purchase status is required to resume purchasing, it shall be re-declared in accordance with the new rules for the application of the drug. 
 
The new application shall be evaluated by quality and credit service. The results are "qualified" and "unqualified". The qualified drugs may be adjusted to the extent that the substandard drugs are not included in the adjustment. Substandard medicines by city medicine authorized committee member units, including but not limited to: within the last two years, and during the period of dynamic adjustment, the violation behavior, the food and drug supervision department at or above the provincial level quality inspection unqualified records (announcement by the state and Shanghai or quality not qualified local food and drug regulator tracking except to sample qualified) or other bad behavior. 
 
The new application shall be subject to the following requirements: 
 
The application of the new drug in 15 provinces and cities shall include two or more provinces and cities, including: 
 
(1) the base product application in the basic scope of the bid: the price should be higher than on the basis of A value 5%, and should not be higher than the same breed (application for drugs with new varieties to define rules see attachment 1) to drug grass-roots scope has bid the lowest price. 
 
The application for the application of the drug is: 
 
(1) has been used in the scope of won the bid of drug at the grass-roots level, to apply for the winning of throughout the whole city, the price should be higher than in the original price and A low value on the basis of A 5% reduction, and should not be higher than the same breed citywide have won the bid the lowest price of medicines. 
 
(ii) not won the bid of drug in this city, can only apply for the winning throughout the whole city, the price should be higher than on the basis of A value 10%, and should not be higher than the same breed citywide have won the bid the lowest price of medicines. 
 
The price listed in the pharmaceutical is not compared with those in the range of the Chinese standard. 
 
(4) low price list range, taking drugs commonly used for western medicine more than 3 yuan/proprietary Chinese medicine for more than 5 yuan, and for the original or quality standard of drugs alone, according to the new application medicine rules (1), (2) or (3) the corresponding provisions. 
 
[2] for new drugs in 15 provinces and cities has not been a province won the bid or bid only, not included in the dynamic adjustment range, except in the case of the following: the original drugs, innovative drugs such as written complaint materials can be provided by the manufacturer, the drug centralized bid procurement affairs management of Shanghai (hereinafter referred to as the "city of pharmaceutical affairs") accept the medicine after recruit committee member list five collective deliberation. 
 
The price tag for the first generic drug entering the Shanghai market should not be higher than 70 percent of the price of the existing drug. 
 
But it is certainly not easy to reenter the list of companies that need to be competitive. 
 
Previous article:Zero tolerance! The health and family planning commission will start soon!
Next article:Three "wolves" of domestic generic drugs have come to a cost war
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号